Evidence map›Paper›PMID 30700796›Full record

ArticleScientific reports2019

Intelectin 3 is dispensable for resistance against a mycobacterial infection in zebrafish (Danio rerio).

Markus J T Ojanen, Meri I E Uusi-Mäkelä, Sanna-Kaisa E Harjula, Anni K Saralahti, Kaisa E Oksanen, Niklas Kähkönen, Juha A E Määttä, Vesa P Hytönen, Marko Pesu, Mika Rämet

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Markus J T OjanenLaboratory of Experimental Immunology, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Meri I E Uusi-MäkeläLaboratory of Experimental Immunology, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Sanna-Kaisa E HarjulaLaboratory of Experimental Immunology, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Anni K SaralahtiLaboratory of Experimental Immunology, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Kaisa E OksanenLaboratory of Experimental Immunology, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Niklas KähkönenLaboratory of Protein Dynamics, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Juha A E MäättäLaboratory of Protein Dynamics, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Vesa P HytönenLaboratory of Protein Dynamics, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0002-9357-1480
Marko PesuLaboratory of Immunoregulation, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0002-7541-3921
Mika RämetLaboratory of Experimental Immunology, BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. mika.ramet@uta.fi.
Tampere University · FITampere University of Applied Sciences · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis is a multifactorial bacterial disease, which can be modeled in the zebrafish (Danio rerio). Abdominal cavity infection with Mycobacterium marinum, a close relative of Mycobacterium tuberculosis, leads to a granulomatous disease in adult zebrafish, which replicates the different phases of human tuberculosis, including primary infection, latency and spontaneous reactivation. Here, we have carried out a transcriptional analysis of zebrafish challenged with low-dose of M. marinum, and identified intelectin 3 (itln3) among the highly up-regulated genes. In order to clarify the in vivo significance of Itln3 in immunity, we created nonsense itln3 mutant zebrafish by CRISPR/Cas9 mutagenesis and analyzed the outcome of M. marinum infection in both zebrafish embryos and adult fish. The lack of functional itln3 did not affect survival or the mycobacterial burden in the zebrafish. Furthermore, embryonic survival was not affected when another mycobacterial challenge responsive intelectin, itln1, was silenced using morpholinos either in the WT or itln3 mutant fish. In addition, M. marinum infection in dexamethasone-treated adult zebrafish, which have lowered lymphocyte counts, resulted in similar bacterial burden in both WT fish and homozygous itln3 mutants. Collectively, although itln3 expression is induced upon M. marinum infection in zebrafish, it is dispensable for protective mycobacterial immune response.

Indexed as

AnimalsBase SequenceCodon, NonsenseCRISPR-Cas SystemsCytokinesDexamethasoneDisease ResistanceEmbryo, NonmammalianGene Expression RegulationGenomeLectinsLymphocyte DepletionMorpholinosMutationMycobacterium Infections, NontuberculousMycobacterium marinumCodon, NonsenseCytokinesDexamethasoneitln3 protein, zebrafishLectinsMorpholinosZebrafish Proteins

Identifiers

PMID30700796
PMCPMC6353920
OpenAlexW2924032916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.